Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Halfdan, Sorbye"'
Autor:
Anne Hansen Ree, Eirik Høye, Ying Esbensen, Ann-Christin R. Beitnes, Anne Negård, Linn Bernklev, Linn Kruse Tetlie, Åsmund A. Fretland, Hanne M. Hamre, Christian Kersten, Eva Hofsli, Marianne G. Guren, Halfdan Sorbye, Hilde L. Nilsen, Kjersti Flatmark, Sebastian Meltzer
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
The randomized METIMMOX trial (NCT03388190) examined if patients with previously untreated, unresectable abdominal metastases from microsatellite-stable (MSS) colorectal cancer (CRC) might benefit from potentially immunogenic, short-course oxaliplati
Externí odkaz:
https://doaj.org/article/a08572504c1241d5a365f6b0a359ede1
Autor:
Sampsa Kinos, Helga Hagman, Päivi Halonen, Leena-Maija Soveri, Mary O'Reilly, Per Pfeiffer, Jan-Erik Frödin, Halfdan Sorbye, Eetu Heervä, Gabor Liposits, Raija Kallio, Annika Ålgars, Raija Ristamäki, Tapio Salminen, Maarit Bärlund, Carl-Henrik Shah, Ray McDermott, Rebecka Röckert, Petra Flygare, Johannes Kwakman, Arco Teske, Cornelis Punt, Bengt Glimelius, Pia Österlund
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: The CardioSwitch-study demonstrated that patients with solid tumors who develop cardiotoxicity on capecitabine or 5-fluorouracil (5-FU) treatment can be safely switched to S-1, an alternative fluoropyrimidine (FP). In light of
Externí odkaz:
https://doaj.org/article/340dd2f28c5441ddaf0adaf8e0022afa
Autor:
Elinor Chelsom Vogt, Kathrin Hammerling, Halfdan Sorbye, Anette Heie, Andre Sulen, Grethe Ueland, Eystein Husebye, Paal Methlie
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2021)
Feminizing estrogen-secreting adrenocortical carcinomas (ACCs) are exceedingly rare and carry a poor prognosis. The most common presenting trait is gynecomastia, but enlarged breasts are also a frequent clinical finding in healthy men. Biochemical ev
Externí odkaz:
https://doaj.org/article/3074993544534e1cb6511173947c6565
Publikováno v:
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-11 (2020)
Abstract Background Patients with metastatic small-intestinal neuroendocrine tumours (NET) have been shown to have a reduced quality of life compared to the general population and many have disabling symptoms during somatostatin analogue (SSA) treatm
Externí odkaz:
https://doaj.org/article/fd6c389817ad48c19235ba047c990641
Autor:
Emerik Osterlund, Ari Ristimäki, Soili Kytölä, Teijo Kuopio, Eetu Heervä, Timo Muhonen, Päivi Halonen, Raija Kallio, Leena-Maija Soveri, Jari Sundström, Mauri Keinänen, Annika Ålgars, Raija Ristamäki, Halfdan Sorbye, Per Pfeiffer, Luís Nunes, Tapio Salminen, Annamarja Lamminmäki, Markus J. Mäkinen, Tobias Sjöblom, Helena Isoniemi, Bengt Glimelius, Pia Osterlund
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundKRAS mutations, present in over 40% of metastatic colorectal cancer (mCRC), are negative predictive factors for anti-EGFR therapy. Mutations in KRAS-G12C have a cysteine residue for which drugs have been developed. Published data on this sp
Externí odkaz:
https://doaj.org/article/decb120b6a4a470ea68f4e7d8f7c7d6d
Autor:
Philip Falk, Mira Severin, Åke Berglund, Marianne G. Guren, Eva Hofsli, Pia Österlund, Anne Tandberg, Jakob Eberhard, Halfdan Sorbye
Publikováno v:
Cancer Treatment and Research Communications, Vol 31, Iss , Pp 100517- (2022)
Background: The incidence of colorectal cancer (CRC) in individuals of fertile age is increasing. Oxaliplatin is a cornerstone treatment in the adjuvant setting for stage III and high-risk stage II CRC. Limited data exist on possible side effects of
Externí odkaz:
https://doaj.org/article/3e6fb0374fb14640929b1684072c3445
Autor:
Kristine Ø. Aasebø, Anca Dragomir, Magnus Sundström, Artur Mezheyeuski, Per‐Henrik Edqvist, Geir Egil Eide, Fredrik Ponten, Per Pfeiffer, Bengt Glimelius, Halfdan Sorbye
Publikováno v:
Cancer Medicine, Vol 8, Iss 7, Pp 3623-3635 (2019)
Abstract Background Immunotherapy for patients with microsatellite‐instable (MSI‐H) tumors or BRAF‐inhibitors combination treatment for BRAF‐mutated (mutBRAF) tumors in metastatic colorectal cancer (mCRC) is promising, but the frequency of th
Externí odkaz:
https://doaj.org/article/4afffda008d14f09a49e47ab6b689b3a
Autor:
Gitte Dam, Henning Grønbæk, Anna Sundlöv, Johan Botling, Anders Sundin, Rene Horsleben Petersen, Staffan Welin, Espen-Thiis Evensen, Halfdan Sorbye, Elizaveta Tabaksblat, Anne Kirstine Arveschoug, Jann Mortensen, Andreas Kjaer, Ulrich Knigge, Eva Tiensuu Janson, Seppo W. Langer
Publikováno v:
Acta Oncologica. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a9662f7341ab7f6ae7549cf1247d1ba
https://doi.org/10.1080/0284186x.2023.2212411
https://doi.org/10.1080/0284186x.2023.2212411
Autor:
Kristine Aasebø, Anca Dragomir, Magnus Sundström, Artur Mezheyeuski, Per-Henrik Edqvist, Geir Egil Eide, Fredrik Ponten, Per Pfeiffer, Bengt Glimelius, Halfdan Sorbye
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Survival of metastatic colorectal cancer (mCRC) patients has improved, but mainly for trial patients. New predictive and prognostic biomarkers validated in the general mCRC population are needed. Caudal-type homeobox 2 (CDX2) is an intest
Externí odkaz:
https://doaj.org/article/b837c69e9b124f41bf850ea28727f6ad
Autor:
Sebastian Meltzer, Anne Negård, Kine M. Bakke, Hanne M. Hamre, Christian Kersten, Eva Hofsli, Marianne G. Guren, Halfdan Sorbye, Kjersti Flatmark, Anne Hansen Ree
Publikováno v:
British Journal of Cancer
Background Immune checkpoint blockade (ICB) results in radiologic tumour response dynamics that differ from chemotherapy efficacy measures and require an early signal of clinical utility. Methods Previously untreated, unresectable microsatellite-stab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11929438b869b5beff41ce292e7e7043
https://doi.org/10.1038/s41416-022-02004-0
https://doi.org/10.1038/s41416-022-02004-0